SLN124
SLN124 is a GalNAc-conjugated siRNA therapeutic targeting TMPRSS6. It is designed to modulate iron homeostasis by inhibiting Tmprss6 expression, showing potential for research in iron overload disorders like β-thalassemia in both in vitro and in vivo models.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
rAP-4501 1 Each
Signaling Threshold Regulating Transmembrane Adaptor 1 Human Recombinant
Sign In for Pricing
View Details 
MBS1184290-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis UPF0435 protein yfkK (yfkK)
Sign In for Pricing
View Details 
MBS1184290-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis UPF0435 protein yfkK (yfkK)
Sign In for Pricing
View Details MBS1184290-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis UPF0435 protein yfkK (yfkK)
Sign In for Pricing
View Details MBS1184290-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis UPF0435 protein yfkK (yfkK)
Sign In for Pricing
View Details MBS1184290-05 0.02 mg (Baculovirus)
Recombinant Bacillus subtilis UPF0435 protein yfkK (yfkK)
Sign In for Pricing
View Details